North South Ventures — 2022 Investments
1 investments dated 2022 · listed companies and verified rows first · show all
YourChoice Therapeuticsychoicetx.cominJul 2022
YourChoice Therapeutics develops YCT-529, a non-hormonal oral contraceptive for men currently in Phase 2 clinical trials that works by blocking a receptor essential for sperm production.
BiotechHealthtechMedical DevicesSan Francisco, US
Akash Bakshi(Founder)inNadja Mannowetz(Founder)in
Co-investorsBlue Bear VenturesForeground CapitalOlive Tree CapitalPortfoliaY CombinatorFuture Ventures+1 more
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.